Clinical Trials

50 trials registered for Age-related macular degeneration

Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.
NCT00359164Phase 2University of British Columbia
Completed
Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD
NCT01269151N/AUniversity of Luebeck
Completed
Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride
NCT01802866Phase 2/3Kubota Vision Inc.
Completed
Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
NCT01345006Phase 1/2Astellas Institute for Regenerative Medicine
Completed
Technology-based Eye Care Services (TECS) Compare
NCT02558712N/AEmory University
Completed
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)
NCT01988662Phase 4Novartis Pharmaceuticals
Completed
Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment
NCT01792141N/ARetina Institute of Hawaii
Completed
Vascular Endothelial Growth Factor (VEGF) in Uveitis
NCT00001738N/ANational Eye Institute (NEI)
Completed
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)
NCT06682455N/AUniversity of Southampton
Enrolling
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
NCT03999801Phase 2AbbVie
Enrolling
Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material
NCT07403825Phase 4Biobizkaia Health Research Institute
Not Yet Recruiting
Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss
NCT07216924N/AUniversity of Minnesota
Not Yet Recruiting
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
NCT06924021N/AUniversity of Wisconsin, Madison
Recruiting
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
NCT04187443Phase 1Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Recruiting
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
NCT04627428Phase 1/2Luxa Biotechnology, LLC
Recruiting
SGLT2 Inhibitors in Geographic Atrophy
NCT07174687Phase 2Washington University School of Medicine
Recruiting
A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
NCT00395057Phase 2Allergan
Terminated
Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)
NCT03133117N/AUniversity Hospital, Grenoble
Terminated
Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)
NCT03577899Phase 3Chengdu Kanghong Biotech Co., Ltd.
Terminated
Genetic Factors in Age-Related Macular Degeneration
NCT00058695N/ANational Eye Institute (NEI)
Terminated
Load more